Tag: William Blair

Paychex (PAYX) Directors Buy 2,000 Shares in February Insider Trades

[ad_1]

Paychex, Inc. (NASDAQ:PAYX) is one of the 12 Dividend Stocks With High Insider Buying.

Paychex (PAYX) Directors Buy 2,000 Shares in February Insider Trades

On February 5, 2026, two top executives at Paychex, Inc. (NASDAQ:PAYX) made bold purchases. The company’s Director, Joseph Doody, acquired 1,000 shares of the company’s stock in a transaction valued at $98,760. Meanwhile, another Director, Tom Bonadio, also purchased 1,000 shares of Paychex, Inc. (NASDAQ:PAYX), in a transaction worth $98,490.

Prior to these purchases, on February 2, 2026, UBS analyst Kevin McVeigh reiterated a Hold rating on Paychex, Inc. (NASDAQ:PAYX), with a price target set at $110. And most recently, on February 10, 2026, William Blair analyst Andrew Nicholas also maintained a Hold rating on the stock.

Additionally, earlier this year, on January 16, 2026, the company announced receiving approval from the Board of Directors to repurchase $1 billion of the company’s common stock, effectively replacing the 2024 authorization of $400 million repurchase. Alongside this announcement, the company’s Board of Directors also declared the quarterly cash dividend of $1.08 per share to shareholders of record as of January 28, 2026. The dividend is payable on February 27, 2026.

Headquartered in New York, Paychex, Inc. (NASDAQ:PAYX) is a leading provider of human capital management solutions for small to medium-sized businesses. The company has been operating since 1971.

While we acknowledge the potential of PAYX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best Pipeline and MLP Stocks to Buy in 2026 and 13 Cheapest Dividend Aristocrats to Invest in.

Disclosure. None.

[ad_2]

Source link

February 17, 2026
Fortrea’s (FTRE) Market Perform Rating Reaffirmed at William Blair

[ad_1]

William Blair reissued their market perform rating on shares of Fortrea (NASDAQ:FTRE – Free Report) in a research note released on Monday morning, Benzinga reports.

FTRE has been the topic of several other research reports. Robert W. Baird upgraded shares of Fortrea from a neutral rating to an outperform rating and lowered their price objective for the stock from $45.00 to $36.00 in a report on Tuesday, May 14th. Barclays started coverage on Fortrea in a research report on Wednesday, July 24th. They issued an equal weight rating and a $30.00 price target for the company. Baird R W upgraded shares of Fortrea from a hold rating to a strong-buy rating in a research report on Tuesday, May 14th. The Goldman Sachs Group began coverage on shares of Fortrea in a report on Thursday, June 6th. They issued a neutral rating and a $28.00 price target on the stock. Finally, TD Cowen initiated coverage on Fortrea in a report on Wednesday, May 29th. They issued a hold rating and a $27.00 price target on the stock. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Fortrea presently has a consensus rating of Hold and an average price target of $30.50.

Read Our Latest Stock Analysis on Fortrea

Fortrea Price Performance

Shares of NASDAQ:FTRE opened at $20.04 on Monday. The firm has a 50 day simple moving average of $24.99 and a 200 day simple moving average of $31.30. The company has a market cap of $1.79 billion and a price-to-earnings ratio of -14.42. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.47 and a quick ratio of 1.47. Fortrea has a one year low of $18.07 and a one year high of $41.02.

Insider Buying and Selling

In other news, General Counsel James S. Hanson bought 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The shares were bought at an average cost of $25.30 per share, with a total value of $50,600.00. Following the completion of the purchase, the general counsel now directly owns 7,475 shares in the company, valued at $189,117.50. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Fortrea news, General Counsel James S. Hanson bought 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were bought at an average cost of $25.30 per share, with a total value of $50,600.00. Following the completion of the purchase, the general counsel now directly owns 7,475 shares of the company’s stock, valued at $189,117.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Thomas Pike purchased 10,000 shares of the stock in a transaction on Wednesday, May 29th. The shares were acquired at an average cost of $24.81 per share, with a total value of $248,100.00. Following the transaction, the chief executive officer now directly owns 57,827 shares in the company, valued at $1,434,687.87. The disclosure for this purchase can be found here. 0.12% of the stock is owned by corporate insiders.

Institutional Trading of Fortrea

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. nVerses Capital LLC purchased a new stake in shares of Fortrea in the 2nd quarter worth approximately $26,000. Allworth Financial LP purchased a new stake in shares of Fortrea during the 4th quarter valued at about $28,000. Glassman Wealth Services bought a new position in Fortrea in the fourth quarter worth approximately $28,000. Gladius Capital Management LP purchased a new position in Fortrea during the second quarter valued at $30,000. Finally, Concord Wealth Partners grew its stake in shares of Fortrea by 152.8% during the 1st quarter. Concord Wealth Partners now owns 862 shares of the company’s stock valued at $35,000 after acquiring an additional 521 shares during the period.

Fortrea Company Profile

(Get Free Report)

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.

Featured Stories

Receive News & Ratings for Fortrea Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Fortrea and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

August 13, 2024
Equities Analysts Offer Predictions for Oracle Co.’s Q1 2025 Earnings (NYSE:ORCL)

[ad_1]

Oracle Co. (NYSE:ORCL – Free Report) – Equities research analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for shares of Oracle in a research report issued on Tuesday, September 12th. William Blair analyst S. Naji forecasts that the enterprise software provider will post earnings of $1.08 per share for the quarter. The consensus estimate for Oracle’s current full-year earnings is $4.50 per share. William Blair also issued estimates for Oracle’s Q2 2025 earnings at $1.18 EPS and Q3 2025 earnings at $1.23 EPS.

Oracle (NYSE:ORCL – Get Free Report) last issued its quarterly earnings data on Monday, September 11th. The enterprise software provider reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.04. The business had revenue of $12.45 billion during the quarter, compared to analysts’ expectations of $12.48 billion. Oracle had a negative return on equity of 470.73% and a net margin of 17.02%. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.81 EPS.

Several other brokerages have also weighed in on ORCL. Guggenheim lifted their price target on Oracle from $120.00 to $150.00 in a research note on Tuesday, June 13th. Bank of America lifted their price target on Oracle from $112.00 to $132.00 in a research note on Tuesday, June 13th. Mizuho lifted their price target on Oracle from $116.00 to $150.00 in a research note on Tuesday, June 13th. Monness Crespi & Hardt lowered Oracle from a “buy” rating to a “neutral” rating in a research note on Tuesday. Finally, Morgan Stanley boosted their price objective on Oracle from $105.00 to $106.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Twelve investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $122.22.

Get Our Latest Analysis on Oracle

Oracle Price Performance

Shares of Oracle stock opened at $113.66 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 55.54. Oracle has a twelve month low of $60.78 and a twelve month high of $127.54. The business has a 50-day moving average price of $117.33 and a 200 day moving average price of $105.89. The firm has a market cap of $308.50 billion, a PE ratio of 37.14, a P/E/G ratio of 3.48 and a beta of 1.00.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 26th. Investors of record on Thursday, October 12th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date is Wednesday, October 11th. Oracle’s dividend payout ratio is presently 52.29%.

Insider Activity at Oracle

In related news, insider Edward Screven sold 354,837 shares of the company’s stock in a transaction that occurred on Tuesday, June 20th. The stock was sold at an average price of $123.39, for a total value of $43,783,337.43. Following the transaction, the insider now directly owns 2,543,033 shares in the company, valued at $313,784,841.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Chairman Lawrence Joseph Ellison sold 1,750,000 shares of the stock in a transaction dated Tuesday, June 20th. The stock was sold at an average price of $123.10, for a total transaction of $215,425,000.00. Following the transaction, the chairman now owns 1,145,732,353 shares of the company’s stock, valued at approximately $141,039,652,654.30. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Edward Screven sold 354,837 shares of the stock in a transaction dated Tuesday, June 20th. The stock was sold at an average price of $123.39, for a total value of $43,783,337.43. Following the transaction, the insider now directly owns 2,543,033 shares in the company, valued at approximately $313,784,841.87. The disclosure for this sale can be found here. Over the last three months, insiders have sold 3,949,837 shares of company stock worth $482,142,887. Insiders own 43.70% of the company’s stock.

Hedge Funds Weigh In On Oracle

Hedge funds have recently bought and sold shares of the company. Horizon Wealth Management LLC lifted its holdings in shares of Oracle by 2.3% in the 2nd quarter. Horizon Wealth Management LLC now owns 3,922 shares of the enterprise software provider’s stock valued at $467,000 after buying an additional 87 shares during the period. Drive Wealth Management LLC lifted its holdings in shares of Oracle by 1.5% in the 2nd quarter. Drive Wealth Management LLC now owns 6,040 shares of the enterprise software provider’s stock valued at $719,000 after buying an additional 91 shares during the period. Folger Nolan Fleming Douglas Capital Management Inc. lifted its holdings in shares of Oracle by 1.2% in the 2nd quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 7,820 shares of the enterprise software provider’s stock valued at $931,000 after buying an additional 91 shares during the period. Noesis Capital Mangement Corp lifted its holdings in shares of Oracle by 3.2% in the 2nd quarter. Noesis Capital Mangement Corp now owns 3,149 shares of the enterprise software provider’s stock valued at $375,000 after buying an additional 97 shares during the period. Finally, Massmutual Trust Co. FSB ADV lifted its holdings in shares of Oracle by 1.7% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 5,963 shares of the enterprise software provider’s stock valued at $710,000 after buying an additional 97 shares during the period. Institutional investors and hedge funds own 42.44% of the company’s stock.

About Oracle

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Articles

Receive News & Ratings for Oracle Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oracle and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

ABMN Staff

Source link

September 15, 2023